At a Glance
| Methylphenidate | 3,4-CTMP | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 20–40 mg | 4–6 mg |
| Total Duration | 1.8–3.3 hrs | 1–2 hrs |
| Routes | insufflatedoral | oral |
Methylphenidate, a Stimulants, and 3,4-CTMP, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 17 documented effects in common, with 8 effects unique to Methylphenidate and 27 unique to 3,4-CTMP. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Methylphenidate | 3,4-CTMP | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 20–40 mg | 4–6 mg |
| Total Duration | 1.8–3.3 hrs | 1–2 hrs |
| Routes | insufflatedoral | oral |
| Effects | 25 documented | 44 documented |
| Level | Methylphenidate | 3,4-CTMP |
|---|---|---|
| Threshold | 5 mg | 2 mg |
| Light | 10–20 mg | 2–4 mg |
| Common | 20–40 mg | 4–6 mg |
| Strong | 40–60 mg | 6–8 mg |
| Heavy | 60 mg | 8 mg |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 2–10 mg |
| Common | 10–30 mg |
| Strong | 30–60 mg |
| Heavy | 60 mg |
Methylphenidate
3,4-CTMP
No direct interaction data available between these substances. This does not mean the combination is safe.